Cano Health (Cano Health) Research & Development : $0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Cano Health Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Cano Health's Research & Development for the three months ended in Mar. 2024 was $0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was $0 Mil.

Cano Health Research & Development Historical Data

The historical data trend for Cano Health's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cano Health Research & Development Chart

Cano Health Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Research & Development

Cano Health Quarterly Data
	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Research & Development	Get a 7-Day Free Trial												-	-	-	-	-

Cano Health Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

Cano Health (OTCPK:CANOQ) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Cano Health Research & Development Related Terms

Thank you for viewing the detailed overview of Cano Health's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Cano Health (Cano Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cano Health Inc (OTCPK:CANOQ) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

N/A

Address

9725 NW 117th Avenue, Suite 200, Miami, FL, USA, 33178

Website

https://www.canohealth.com

Cano Health Inc operates value-based primary care centers and supports affiliated medical practices that specialize in primary care for seniors in Florida, Texas, Nevada, and Puerto Rico.

Executives

Elliot Cooperstone	director, 10 percent owner	C/O CANO HEALTH, INC., 9725 NW 117TH AVENUE, SUITE 200, MIAMI FL 33178
Eladio Gil	officer: Interim CFO	9725 NW 17TH AVENUE, SUITE 200, MIAMI FL 33178
Robert Camerlinck	officer: Chief Operating Officer	9725 NW 117TH AVENUE, SUITE 200, MIAMI FL 33178
Richard Aguilar	officer: Chief Clinical Officer	9725 NW 117TH AVENUE, SUITE 200, MIAMI FL 33178
Mark D. Kent	officer: Interim CEO	9725 NW 117TH AVENUE, SUITE 200, MIAMI FL 33178
David J Armstrong	officer: See Remarks	9725 NW 117TH AVENUE, SUITE 200, MIAMI FL 33178
Brian D Koppy	officer: Chief Financial Officer	9725 NW 117TH AVENUE, SUITE 200, MIAMI FL 33178
Lewis Gold	director	1235 SPANISH RIVER ROAD, BOCA RATON FL 33432
Marlow Hernandez	director, officer: See Remarks	9725 NW 117TH AVENUE, SUITE 200, MIAMI FL 33178
Solomon D Trujillo	director	1000 NICOLLET MALL, TPS-3255, MINNEAPOLIS MN 55403
Alan Muney	director	48 MONROE TURNPIKE, TRUMBULL CT 06611
Kim M Rivera	director	601 HAWAII ST, EL SEGUNDO CA 90245
Itc Rumba, Llc	10 percent owner	444 MADISON AVENUE, 35TH FLOOR, NEW YORK NY 10022
Jacqueline Guichelaar	director	C/O CANO HEALTH, INC., 9725 NW 117TH AVENUE, SUITE 200, MIAMI FL 33178
Angel L Morales	director	C/O CANO HEALTH, INC., 9725 NW 117TH AVENUE, SUITE 200, MIAMI FL 33178